SG11201607996SA - Effect of lipophilic nutrients on diabetic eye diseases - Google Patents

Effect of lipophilic nutrients on diabetic eye diseases

Info

Publication number
SG11201607996SA
SG11201607996SA SG11201607996SA SG11201607996SA SG11201607996SA SG 11201607996S A SG11201607996S A SG 11201607996SA SG 11201607996S A SG11201607996S A SG 11201607996SA SG 11201607996S A SG11201607996S A SG 11201607996SA SG 11201607996S A SG11201607996S A SG 11201607996SA
Authority
SG
Singapore
Prior art keywords
effect
eye diseases
diabetic eye
lipophilic nutrients
lipophilic
Prior art date
Application number
SG11201607996SA
Inventor
Jayant Deshpande
Shankaranarayanan Jeyakodi
Original Assignee
Omniactive Health Technologies Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Omniactive Health Technologies Ltd filed Critical Omniactive Health Technologies Ltd
Publication of SG11201607996SA publication Critical patent/SG11201607996SA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/075—Ethers or acetals
    • A61K31/085—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon
    • A61K31/09—Ethers or acetals having an ether linkage to aromatic ring nuclear carbon having two or more such linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9066—Curcuma, e.g. common turmeric, East Indian arrowroot or mango ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/906—Zingiberaceae (Ginger family)
    • A61K36/9068—Zingiber, e.g. garden ginger
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38—Cellulose; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/12—Ophthalmic agents for cataracts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/328—Foods, ingredients or supplements having a functional effect on health having effect on glycaemic control and diabetes
SG11201607996SA 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases SG11201607996SA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/IB2015/052248 WO2015145389A2 (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases
IN1128MU2014 IN2014MU01128A (en) 2014-03-28 2015-03-26

Publications (1)

Publication Number Publication Date
SG11201607996SA true SG11201607996SA (en) 2016-11-29

Family

ID=54196517

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11201607996SA SG11201607996SA (en) 2014-03-28 2015-03-26 Effect of lipophilic nutrients on diabetic eye diseases

Country Status (13)

Country Link
US (1) US20170143646A1 (en)
EP (1) EP3122339A2 (en)
JP (1) JP2017511380A (en)
KR (1) KR20160140859A (en)
CN (1) CN106163536A (en)
AU (1) AU2015237806A1 (en)
CA (1) CA2943921A1 (en)
IL (1) IL248016A0 (en)
IN (1) IN2014MU01128A (en)
MX (1) MX2016012625A (en)
PH (1) PH12016501914A1 (en)
SG (1) SG11201607996SA (en)
WO (1) WO2015145389A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017137294A (en) * 2016-01-29 2017-08-10 静岡県公立大学法人 Composition for delivery of zingiberaceae plant extract
WO2017179028A1 (en) * 2016-04-16 2017-10-19 Omniactive Health Technologies Limited Method for treatment of visual stress conditions and compositions used therein
US20180168182A1 (en) * 2016-12-21 2018-06-21 Muhammed Majeed Chewable compositions containing curcuminoids and their method of preparation
WO2019050542A1 (en) * 2017-09-11 2019-03-14 Verdure Sciences Methods and compositions for the treatment of retinal, neurological and other related diseases
CN108421020A (en) * 2018-05-29 2018-08-21 李玉梅 It is a kind of to be used to treat Ginger P.E of diabetic retinopathy and its preparation method and application
US11135179B1 (en) 2018-12-28 2021-10-05 QH Holdings (Oregon), Inc. Eye health supplement
US11141386B1 (en) 2018-12-28 2021-10-12 QH Holdings (Oregon), Inc. Eye health supplement with curcumin
US20220193008A1 (en) * 2019-04-26 2022-06-23 Shankaranarayanan JEYAKODI Bioaccessibile compositions of lipophilic compounds and process thereof
WO2020223832A1 (en) * 2019-05-06 2020-11-12 高思 Eye-nourishing and eyesight-improving herbal candy containing nutrients for human eye lens and retinal photosensitive cells
CN112006282A (en) * 2020-09-04 2020-12-01 北京瑞济善健康科技有限公司 Composition for repairing diabetic complications and preparation method and application thereof
DE102022122731A1 (en) * 2022-09-07 2024-03-07 Ruma Gmbh Metabolizable control markers for endogenous urine labeling

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3998753A (en) * 1974-08-13 1976-12-21 Hoffmann-La Roche Inc. Water dispersible carotenoid preparations and processes thereof
US6737535B2 (en) 2002-06-05 2004-05-18 Kancor Flavours And Extracts Limited Trans-lutein enriched xanthophyll ester concentrate and a process for its preparation
US6743953B2 (en) 2002-08-26 2004-06-01 Kancor Flavours & Extracts Ltd. Process for the preparation of xanthophyll crystals
US20060088574A1 (en) * 2004-10-25 2006-04-27 Manning Paul B Nutritional supplements
US20100240581A1 (en) * 2006-11-13 2010-09-23 The Trustees Of Columbia University In The City Of New York Selective proteasome inhibitors for treating diabetes
US20080181972A1 (en) * 2007-01-29 2008-07-31 Valentina Amico Compositions and Methods for Maintaining, Strengthening, Improving, or Promoting Eye Health
EP2326338B1 (en) 2008-09-22 2015-08-05 Innoveda Biological Solutions (P) Ltd. A herbal formulation for prevention and treatment of diabetes and associated complications
EP2427174A4 (en) 2009-05-04 2014-01-15 Santen Pharmaceutical Co Ltd Mtor pathway inhibitors for treating ocular disorders
PT2473065E (en) * 2009-09-02 2016-06-03 Omniactive Health Tech Ltd A xanthophyl composition containing macular pigments and a process for its preparation
US20110300246A1 (en) * 2010-06-03 2011-12-08 Qinheng Huang Herbal Extracts for Treatment of Diabetic Complications and Oxidative Stress
PL2433640T3 (en) 2010-09-24 2020-06-01 Omnivision Gmbh Composition comprising SOD, lutein and zeaxanthin
CN102178925A (en) 2011-04-25 2011-09-14 崔晓廷 Novel eyesight protective agent lutein ophthalmic preparation
CN102225087A (en) * 2011-06-09 2011-10-26 雷爱林 Xanthophyll compound preparation with powerful eye-protecting effect
AU2014242655A1 (en) * 2013-03-28 2015-10-22 Omniactive Health Technologies Limited Neuroprotective effect of carotenoids in brain
CN103238902B (en) * 2013-05-23 2014-12-03 云南瑞宝生物科技有限公司 Juice powder and preparation method thereof

Also Published As

Publication number Publication date
PH12016501914A1 (en) 2017-01-09
IN2014MU01128A (en) 2015-10-02
WO2015145389A2 (en) 2015-10-01
CA2943921A1 (en) 2015-10-01
CN106163536A (en) 2016-11-23
US20170143646A1 (en) 2017-05-25
KR20160140859A (en) 2016-12-07
MX2016012625A (en) 2017-01-09
AU2015237806A1 (en) 2016-10-20
EP3122339A2 (en) 2017-02-01
IL248016A0 (en) 2016-11-30
JP2017511380A (en) 2017-04-20
WO2015145389A3 (en) 2015-11-26

Similar Documents

Publication Publication Date Title
IL248016A0 (en) Effect of lipophilic nutrients on diabetic eye diseases
IL252839A0 (en) Treatment of pemphigus
IL248431B (en) Syringe with rolling diaphragm
HK1223054A1 (en) Wearable transdermal neurostimulator
IL246661B (en) Human antibodies to pd-l1
EP3223894A4 (en) Textile patient interface
EP3122414A4 (en) Venous disease treatment
AU362912S (en) Wristband
SG11201506309SA (en) Eye massager
GB201416281D0 (en) Vegetation catergorisation
EP3209331C0 (en) Ophthalmic solution
IL250017A0 (en) Ophthalmoscopes
HK1205924A1 (en) Eye massager
GB201402692D0 (en) Synthetic retina
EP3185825A4 (en) Surgical eye shield
PL3020268T3 (en) Baler twine-delivery needle
EP3192452A4 (en) Medical needle
TWM488998U (en) Syringe
HUE036515T2 (en) Mulcher
EP3145532A4 (en) Individualized treatment of eye disease
SG11201704819WA (en) Syringe
GB201414366D0 (en) Blood defence
GB2555761B (en) Disposable eye patch/shield
PL2987519T3 (en) Hypodermic needle
GB201413986D0 (en) Saline drug